Biotech Values

[rkrw]

Seems there must be more to the Topol/AGIX story. His actions are the top and strange, even slander. A friend of mine wonders how agix can have CC do the rest of the ivus analysis?

I still bet agix gets acquired or has a MAJOR jv well before the arise data are in.

Here's some news on epix, agix isn't the only one with unreadable scans

FDA Extends New Drug Application -- NDA -- Action Date for EPIX's MS-325 to mid-January 2005

The extension stems from recent submissions, at the FDA's request, of additional analyses of previously submitted data. One of these submissions has been classified by the Agency as a major amendment that extends the FDA action date. EPIX's post-application submissions include several analyses relating to non-contrast MR imaging, uninterpretable scans, and subgroup analyses by scanner type, geographic location, vessel bed and readers. FDA regulations provide for a three-month extension period, which would result in a revised FDA action date deadline of mid-January 2005. The extension notification by the FDA did not include a request for any new data.